发明名称 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
摘要 A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein R 1 represents a C 1 -C 12 alkyl; R 2 represents a hydrogen atom or the like; R 3 represents a halogen or the like; q represents an integer of 1 to 7; R 4 represents a halogen or the like; p represents 0 or an integer of 1 to 5; R 5 represents a C 6 -C 10 aryl, a heterocycle or the like; and X represents oxygen, NH, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).
申请公布号 EP2261224(A2) 申请公布日期 2010.12.15
申请号 EP20100010448 申请日期 2005.09.29
申请人 MITSUBISHI TANABE PHARMA CORPORATION;SANOFI-AVENTIS 发明人 WATANABE, KAZUTOSHI;FUKUNAGA, KENJI;KOHARA, TOSHIYUKI;UEHARA, FUMIAKI;HIKI, SHINSUKE;YOKOSHIMA, SATOSHI
分类号 C07D401/04;A61K31/505;A61K31/506;A61P25/28;C07D401/14;C07D409/14;C07D413/14 主分类号 C07D401/04
代理机构 代理人
主权项
地址